URMC / Research / Clinical Trials / Study Details Study of Arimoclomol in Inclusion Body Myositis (IBM) Basic Study Information Purpose:Funding Source - FDA OOPD. The purpose of this study is to evaluate the safety and efficacy of the study drug, Arimoclomol in IBM patients. Location: University of RochesterLead Researcher (Principal Investigator) Lead Researcher: Elizabeth Luebbe Study Contact InformationStudy Coordinator: Liz LuebbePhone: 585-275-7867Email: elizabeth_luebbe@urmc.rochester.edu Additional Study Details Contact This Study First Name * This field is required Middle Name Last Name * This field is required Phone Number Email I agree to be contacted by The University of Rochester Medical Center regarding participation in this study. *You must agree to be contacted to continue. Please call me during the day. Please call me during the evening. Message Thank you for contacting us. People like you are helping URMC make our community and world a healthier place. We sincerely appreciate your effort. A member of our research team will be in touch with you. URMC / Wilmot Cancer Institute /Research / Clinical Trials / Study Details Trial Not Found The study you are looking for is not active at this time. Return to Search